Latest News

From connections between cannabis use and schizophrenia to some non-psychiatric medications that may worsen symptoms of major depression, here are highlights from the week in Psychiatric Times.
The Week in Review: September 25-29

September 30th 2023

From connections between cannabis use and schizophrenia to some non-psychiatric medications that may worsen symptoms of major depression, here are highlights from the week in Psychiatric Times.

Here are some updates from the world of psychiatry throughout the month of September.
Psychiatry in the News: September 2023

September 29th 2023

The treatment, if approved, “will represent the first novel pharmacological approach to treating schizophrenia in several decades and provide a new treatment option for patients and their physicians.”
NDA Submitted for Investigational Muscarinic Antipsychotic in the Treatment of Schizophrenia

September 28th 2023

A look at the association between cannabis use and schizophrenia, as well as the need for comprehensive public health policies and education.
Cannabis and Schizophrenia: Implications in the Legalization Era

September 25th 2023

Here’s what the historic case of the Genain quadruplets reveals about some deeper, uncomfortable truths about American society.
Girls and Their Monsters, Part 3

September 18th 2023

Latest CME Events & Activities

2022 Annual Psychiatric Times™ World CME Conference™ - Day One

View More

2022 Annual Psychiatric Times™ World CME Conference™ - Day Two

View More

2022 Annual Psychiatric Times™ World CME Conference™ - Day Three

View More

Recognizing Rett Syndrome Early to Improve Long-Term Management Outcomes

Register Now!

Shaping the Management of Multiple Sclerosis – The Potential for BTK Inhibitors in Clinical Practice

View More

Transforming Multiple Sclerosis Care – Clinical Updates on the Effects of BTK Inhibitors

10/13/2023

Register Now!

2023 Annual Psychiatric Times™ World CME Conference

View More

From Clinical Trials to Clinical Practice – Incorporating Screening and Assessment Strategies for the Early Diagnosis of Alzheimer Disease

View More

Taking Pompe Disease Management to the Next Level: Optimizing Clinical Assessments and Treatment Decision-Making

View More

Addressing Healthcare Inequities in Stroke Care: How Can We Play an Active Role in Improving Outcomes for All Patients?

View More

2022 4th Annual International Congress on the Future of Neurology

View More

Understanding Best Care Practices for Hemorrhagic Stroke – A Focus on the Role of DOAC Reversals

View More

Clinical Consultations™: Integrating Modern Antipsychotic Medications into the Management of Patients with Schizophrenia

View More

Collaborating Across the Continuum™ : Managing Relapsing MS – A Focus on the Utility of CD20-Targeted B-Cell Therapy

View More

Patient, Provider, and Caregiver Connection™: Challenges in Diagnosis and Management for Patients with ADHD During the COVID-19 Pandemic

View More

Expert Illustrations & Commentaries™: A Family Physicians’ Guide to Migraine Treatment – Emerging Therapies and Evolving Paradigms

View More

PER® Postgame™: MS Meeting Updates – Integrating the Latest Data to Optimize Care in the COVID-19 Era

View More

Medical Crossfire®: What Strategies Can the Care Team Implement to Optimize the Management of Pediatric Patients with NF1?

View More

Expert Illustrations & Commentaries™: Visualizing the Role of Antipsychotics in the Management of Schizophrenia: What is the Role of TAAR1?

View More

Patient, Provider, & Caregiver Connection: Individualizing Care in Multiple Sclerosis – Understanding Patient Challenges and the Role of Innovative Treatment

View More

BURST CME™: Taking ALS Management to the Next Level

View More

FAQs in MS: Exploring Provocative Questions From MS Meeting Updates

View More

The Expanding Role of Fluid Biomarkers in the Diagnosis and Management of Patients With Alzheimer Disease

View More

Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis

View More

Improving Care for Patients with Motor Complications of Parkinson Disease: Role of Technology and Data

View More

Clinical Consultations™: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis

View More

Expert Illustrations & Commentaries™: Visualizing New Therapeutic Targets in Schizophrenia

View More

Advances In™ Schizophrenia: Expanding the Therapeutic Landscape

View More

Advances In Treating Migraine in Your OB/GYN Practice: Navigating Treatment Paradigms to Improve Patient Care

View More

More News

© 2023 MJH Life Sciences

All rights reserved.